T he restoration of maximal conductance (C max ) in animals after arterial occlusion remains defective (35% in the canine coronary circulation 1 and 40% in the rabbit hind limb 2 ) in spite of the fact that normal resting blood flow is reached early. As a consequence exercise testing in experimental animals reveals defects similar to those in human patients. 3 It was not known until now whether collateral vessels are potentially able to restore the full dilatory reserve of a normal vascular bed. Many observations would predict that this is not the case: the multitude of small vessels that replace an occluded artery is inefficient according to Poissieulle's Law, and the tortuosity of collateral vessels offers finite resistance because of curvature flow and increased collateral length. 4 One reason for the defective adaptation may lie in the fact that fluid shear stress normalizes prematurely: FSS falls by the third power of the growing radius. We tested the hypothesis whether a sustained increase of FSS is able to prolong the growth process and to restore normal maximal conductance. The method to achieve this was the creation of a shunt between the distal stump of the occluded femoral artery and the accompanying vein. 5 The novelty of the present findings is the demonstration that C max can be reached and even surpassed by a drastic increase of fluid shear stress. Signaling pathways involved in the adaptation to fluid shear stress were interrogated, and it could be shown that three pathways have to converge to induce arterial growth, ie, the Ras-ERK pathway, the Rho-, and the NO-pathway.
Materials and Methods
An expanded Materials and Methods section can be found in the supplement available at http://circres.ahajournals.org.
We subjected rabbits to femoral artery occlusion and studied the effects of an arteriovenous shunt on the development of the collateral circulation ( Figure 1 ). We measured collateral blood flow by ultrasonic flow probes and by MRI. The morphology of the vessels was studied in vivo by CT-scanning and post mortem by arteriography following pressure-controlled contrast medium injection. Col-lateral artery tissue was prepared for RNA extraction, which was fashioned for microarray studies and for Western blot analysis. Animals were treated with a variety of tool drugs to interrogate the NO, Rho-, and Ras pathways. Smooth muscle cells in culture were treated with several agents used in the pharmacological in vivo studies.
Results
No animals were lost because of the surgical procedure or postoperatively. Clinical signs of peripheral ischemia were transiently present in a few animals but did not lead to ulceration or amputation. In two thirds of the treated animals, the A-V shunt was still open at termination of the experiment. Only animals with a functional shunt were included in the study.
Hemodynamics
Immediately after occlusion of the femoral artery blood pressure in the peripheral stump of the occluded artery fell to low values of 31Ϯ4.2% of the aortic pressure. Peripheral pressure rose to 50Ϯ8% after 7 days and remained at that level for several weeks. In contrast, in animals with femoral artery ligature and an additional A-V shunt the peripheral arterial pressure dropped to 6Ϯ1% of the arterial pressure (immediately after the operation), increased within 7 days to 17Ϯ3%, and reached 29Ϯ3% after 4 weeks. When the shunt was occluded-routinely done during the terminal experiment-7 days after femoral artery occlusion, peripheral pressure increased to 60Ϯ3% of the aortic pressure and to 73Ϯ1% when measured 4 weeks after femoral artery occlusion.
Collateral blood flow ratio (shunt versus control side) measured by MRI was 5.8Ϯ0.8 at day 7 and 13.7Ϯ3.7 at day 28. One week after shunt treatment calculated C max values under optimal vasodilatation were 88Ϯ4% of C max of nonoccluded legs, representing a 2-fold increase in comparison to C max of control ligated legs (44Ϯ7%). After 4 weeks, shunt treated legs showed a C max of 199Ϯ19% of nonligated legs. In contrast, legs with control ligatures did not show any further improvement after 4 weeks when compared with the results after 1 week (Figure 2A ).
Effects of Pharmacological Inhibitors
Fasudil, a Rho-pathway inhibitor, and L-NAME and L-NNA, both inhibitors of endothelial NO synthetase (eNOS), almost completely blocked the positive effects of high shear stress on collateral artery growth (shunt 306Ϯ15 versus Fasudil 176Ϯ4 versus L-NAME 163Ϯ8 versus control 155Ϯ27 mL/min/ 100 mm Hg) ( Figure 2B) .
Moreover, the hypothesis that shear stress leads to an uncoupling of eNOS resulting in increased production of oxygen-and nitrogen-based radicals was investigated. To demonstrate such an effect, 3-Morpholinosydnonimine (Sin-1), which acts as a NO-and superoxide anion radical donor (both react to produce peroxinitrite), was infused but arteriogenesis was inhibited in a dose-dependent manner. In contrast, infusion of the scavengers Ebselen, urate, catalase, and superoxide dismutase showed no effect (data not shown).
Angiography and Computerized Tomography
Postmortem angiograms ( Figure 3A and 3B) showed marked increases in the number of enlarged collaterals on the shunt side (day 7: 42Ϯ2.5 versus 18Ϯ0.95 [control]; day 28: 48Ϯ2.3 versus 12Ϯ2.0 [control]), which corresponded with the number and size of collaterals detected in vivo by CT ( Figure 4A and 4B). Treatment with Fasudil or L-NAME resulted in a significant decrease in collateral count (fasudil 31Ϯ0.9 versus L-NAME 23.8Ϯ1.2 versus shunt 42Ϯ2.5). In contrast to the natural course of collateral growth, which leads to the elimination of most vessels that had initially participated in the growth transformation in favor of a few large ones ("pruning"), no pruning had occurred on the shunt side without further treatment: all preexistent arteriolar connections had enlarged and stayed that way.
High Shear Stress Activates the Ras/ERK Pathway and Increases H-Ras Protein Levels
Using antibodies that react specifically with dual (Thr202/ Tyr204) phosphorylated extracellular signal-regulated kinases (ERK), an activation of ERK-1 and ERK-2 in fluid shear stress induced collaterals was detected in Western blot analysis. Quantitative analysis showed that levels of phosphorylated (activated) ERK-1 and ERK-2 were increased in both cytosolic (2.5-fold) and particulate fractions (1.5-fold) obtained from collateral arteries of the shunted side when compared with collaterals of the control side. This shear stress-induced ERK activation was abrogated by L-NAME. Total ERK-1 and ERK-2 protein levels showed no difference between control and shunted side collaterals with or without L-NAME treatment ( Figure 5) .
We next sought to analyze expression levels of H-Ras in collaterals from the shunted and control side. H-ras is a member of GTP-binding proteins of small molecular weight, known to act as biological switches for various cellular processes. As shown in Figure 6A , Western blot analyses showed a 2.3-fold increase in expression of H-Ras on the shunted side. This effect was reduced by 50% if shunt collaterals were additionally treated with L-NAME ( Figure 6C ). Western blot analysis revealed that neither shear stress nor inhibition of NO synthesis by L-NAME influence the activation of SEK/MKK4, an upstream activator of JNK, and Akt kinase ( Figure 6D ). No differences in P-SEK1/MKK4 levels were observed when comparing collaterals of control and shunted side. Furthermore, no differences in P-SEK1/MKK4 levels were detectable when collaterals of the shunted side (without L-NAME) were compared with collaterals of shunted side with L-NAME. Moreover, FSS and L-NAME treatment did not change the levels and specific phosphorylation (activation) of Akt kinase ( Figure 6F ).
Microarray Expression Profiling and Pathway Analysis
For details see supplemental methods section.
SNAP and L-NAME (But Not L-NNA) Inhibited Cell Proliferation in MVSMC
Discussion
That flow determines arterial size, ie, that form follows function, was known for a long time. Thoma, 6 Schretzenmayr, 7 Rodbard, 8 Langille, 9 Holtz, 10 Tronc, 11 and Ben Driss 12 made the observation that arterial size depends on flow during development, that adult arteries respond with structural changes to changes in blood flow, and that the lumen is controlled by "an immediate physiological adjustment in vascular tone induced by the change in flow, and a delayed anatomical change that occurs when the change in flow persists". Thereafter many studies identified a host of molecules (vasoactive, growth regulatory, inflammatory, adhesive) whose endothelial production is also mediated by fluid shear stress. [13] [14] [15] Recent studies by the laboratories of Figure 2 . A, Maximum collateral conductances (C max ) after control-ligature (control) and ligature in combination with shunt-treatment (shunt) in % of C max without ligation (nonligated). C max after ligature is not able to reach C max of nonligated femoral arteries. One week after ligature in combination with shunt treatment C max is similar to that of nonligated arteries, and after 4 weeks, it had doubled. B, C max after shunt-ligature (shunt) and after control-ligature (ligature) in comparison to C max after shunt treatment in combination with application of Fasudil or L-NAME. Fasudil and L-NAME abolished the shunt-effect. C, Visible collateral arteries in postmortem angiographies were counted and are shown as the collateral count. The values after shunt-treatment (shunt), shunt-treatment plus Fasudil or L-NAME, and controlligature (ligature) are depicted.
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Tedgui, 16 -18 Busse, 19 Dejana, 20 and from our own group 21 have shed light on the mechanisms of transduction of the mechanical stimulus into a growth response.
The most important present new findings are that markedly increased fluid shear stress, created by high shunt flows, overcomes the anatomical restrictions of collateral vessels and leads to complete normalization and overcompensation of maximal conductance. The pathways involved are the Ras-Raf-MEK-ERK-and the Rho-pathway. NO plays an important but complex role.
An often-repeated observation is that the spontaneous growth of collateral arteries remains defective in that only Ϸ35% to 40% of the maximal physiological resistance is restored after arterial occlusion. 1, 22 This defect in the natural restoration of maximal conductance was often tried to ameliorate with the application of angiogenic growth factors, but even in the rigorous studies by Unger 23, 24 high doses of FGF-2 increased C max from only 40% to 50% of C max . One explanation for the limited usefulness of growth factors could be that because of anatomical restrictions collateral vessels had reached their limit and even if further stimulated do not respond with a functional improvement. The tortuosity of collateral vessels, leading to energy-wasting curvature flow, their increase in length, and the relatively large number of small vessels would make them inefficient from the viewpoint of Poissieulle's Law. 4 However, if this defective natural restoration is caused by premature normalization of FSS by the initial increases in collateral diameter, (which reduces FSS by the third power of the radius), an increase in FSS should lead to further growth. In our distal-stump arteriovenous shunt experiments we show for the first time that collateral vessels are not growth-limited and that their mentioned shortcomings do not restrict the restoration of maximal collateral blood flow. In fact, their growth is finally only limited by the size of the surgical anastomosis and by the increased flow-load on the heart. Four weeks after installment of the shunt, the collateral vessels are able to conduct twice as much maximal blood flow compared with the normal femoral artery bed (see Figure 2a ). It could be argued that even under the conditions of the shunt, FSS should fall with the radius in 3rd power caused by the enlargement of the collateral vessels. However because the venous system acts like a flow sink, Poissieulle's law with the radius in the 4th power applies in the absence of a flow limiting peripheral resistance, creating a positive feedback loop.
Arteriogenic Pathways
Our present studies provide evidence for 3 signaling pathways in addition to the already described cell-cell interaction largely based on bone marrow-derived cells adhering to activated endothelium. 25, 26 The 3 signaling pathways are the Ras-ERK pathway, the Rho-pathway, and the NO-pathway. For the RAS-ERK pathway we could show a marked increase of phosphorylation in Western blots of collateral vessel tissue. Whereas the protein amount of ERK did not change, that of Ras had increased. The RAS-ERK pathway plays a prominent role in the transmission of growth factor-initiated signals leading to cell proliferation. 27 It is therefore not 
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surprising to find members of that signaling chain in high activity in growing collateral vessels. However, within the constraints of the present experiment, we cannot identify with any certainty the growth factor(s) that had caused this. Our observation that classical growth factors did not show changes of expression in the microarray screen makes their role uncertain. A new finding is the prominent role of the Rho-pathway in arteriogenesis, which is based on the observed upregulation of RhoA itself, and members of the Rho signaling chain like 
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Circulation Research September 15, 2006 cofilin (CFL1), vimentin and the increased protein expression, and increased degree of phosphorylation of focal adhesion kinase (FAK). Furthermore, the Rho inhibitor Fasudil inhibited arteriogenesis. Although the Rho-pathway is essential for cell motility, necessary for collateral remodeling, a role in smooth muscle cell proliferation was also discussed in a recent review. 28 Its main role lies in the modification of the actin cytoskeleton via cofilin and destrin as we could recently show 29 and confirm with our present microarray experiments. The dissolution of the contractile phenotype of the SMCs is a prerequisite for their mobility during remodeling 30 and is paralleled by the transcriptional downregulation of alpha smooth muscle actin. Cofilin exists in 2 forms: cofilin1, which is expressed in endothelial cells, and cofilin 2, which is expressed in smooth muscle cells. The cofilins are activated by effectors of Rho GTPases, involving LIM kinases, and the phosphatase slingshot. The fact that focal adhesion kinase is also increased in SMCs indicates that this flow sensing system is probably also a general stress sensor in SMCs that are under increased circumferential wall stress because of the vasodilating influence of NO. The high pressure-and stretchrelated forces must now be borne by the SMCs alone because the elastin skeleton had dissolved under the influence of the monocyte elastase. 31 High fluid shear stress is one of the activators of eNOS. 32, 33 It is therefore not surprising to discover that NO plays a role in arteriogenesis which is highlighted by our previous finding of its strong expression in growing collateral vessels 31 and by the almost complete inhibition of the shunt effect by treatment with L-NAME which also caused a shutdown of the RAS-ERK pathway. The role of eNOS may be more complex than the clear-cut L-NAME effect at first suggests, because NO is a known antimitogen for SMCs 32 and it prevents leukocyte adhesion which we showed is crucial for collateral vessel remodeling. 26 Our studies with cultured smooth muscle cells treated with the NO donor SNAP in nontoxic concentrations showed a marked 50% reduction of 3H THymidine uptake. L-NAME, apart from its inhibitory action on eNOS, 45 is a known antiproliferative agent for vascular smooth muscle and an inhibitor of the cell cycle 34 which we also confirmed in SM cell culture studies. Reports on the negative effects of L-NAME on positive remodeling of large conductance arteries under high fluid shear stress 35 may therefore allow for a different interpretation. However, L-NAME is not the most specific antagonist of eNOS, and we tried therefore the more specific antagonist L-NNA in our shunt studies and found that it exerted also a marked antiarteriogenic effect without exhibiting an antiproliferative effect in cultured smooth muscles cells. This strengthened the NO-hypothesis beyond reasonable doubt but did not eliminate the complexity of the action of NO because of the strong antiproliferative action of NO itself, because NO donor infusion did not increase C max , and because eNOS overexpression in transgenic mice does not stimulate arteriogenesis. 36, 37 We hypothesize therefore that NO, produced by high shear stress, most probably induces a Rho-activating factor. Both pathways, the NO as well as the Rho-pathway, assume equal rank because the inhibition of either one inhibits arteriogenesis. The final common pathway for both Rho-and NO is most probably the Ras/ERK signaling chain.
We explored yet another hypothesis: an uncoupling of eNOS may have happened under the influence of the intense and long lasting shear stress 38 and under the influence of oxygen based radical production. 39 NO plus superoxide might have given rise to the formation of peroxinitrite, a radical recently described as being involved in vascular remodeling. 16, 40 Radical scavengers like Ebselen and urate had no effect on C max and the peroxiradical donor SIN-1 markedly and significantly decreased collateral conductance thereby refuting this hypothesis.
Our own present and previous findings would favor the view that stress-induced deformation of the endothelial cell and the change in cytoskeletal tension and arrangement may initiate signals that lead to a variety of responses that act in concert 41, 42 : chemokine expression, 2 adhesion molecule production, 43 marked upregulation of integrins, 44 Rho-activation (present report), and NO-production. 31 
Conclusion
Sustained high fluid shear stress caused by a surgically created shunt between the distal end of an occluded femoral artery and its accompanying vein leads to a much prolonged growth process of collateral arteries which completely restores full maximal conductance, even surpassing normal maximal conductance of a normal arterial bed by a factor of 2. At least 3 signaling pathways converge, ie, the RAS-ERK-, the Rho-, and the NO-pathway, which enable the substantial and sustained growth of collateral arteries and allow for the great range of adaptation potential.
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Detailed description of all methods and of the Micro-array results

Methods
The present study was performed according to Section 8 of the German Law for the Protection of Animals, which confirms to the US National Institutes of Health (NIH) guidelines. Flow was measured at a transverse plane 1cm distal to the aortic bifurcation. Four separate regions of interest (ROI) for each common iliac artery and common iliac vein covered each vessel entirely. Twelve to 18 velocity measurements per heart cycle were acquired for the heart rate range observed (125-180/min).
Anesthesia and Surgery
The cumulative flow (ROI area x mean velocity) per heart cycle, given in ml, was calculated to access shunt effects. Results for each, the shunted as well as the non- 
Computerized Roentgen Tomography (CRT)
All examinations were performed on a 16 row CT scanner (Somatom Sensation Cardiac, Siemens Medical Systems). A contrast-enhanced angiogram was acquired using 1.7 ml/kg body weight of iodinated contrast medium with 400 mg iodine/ml (Imeron 400, Altana Pharma, Konstanz, Germany). The contrast medium was injected by hand at 2 ml/s, followed by a 5 ml saline flush.
The image acquisition started automatically four seconds after a predetermined threshold of 120 Houndsfield units (HU) in a ROI over the descending thoracic aorta was exceeded.
Parameters of the raw 16row-spiral images were: collimation 0.75 mm, 0.5 s rotation time, table feed 15 mm/rot, pitch 1.25, 120 kV, 100 mAs. An acquisition time of 9-11 sec sufficed to cover the distal abdominal aorta to the rabbit's foot at the arterial enhancement phase.
From these raw images, transverse images were calculated with 0.75 mm slice thickness, and 0.5mm image spacing, with the reconstructed FOV measuring 150 mm and a 512 x 512 matrix size. Volume rendering (VR) images were constructed from these images for further evaluation.
Hemodynamic measurements
For the terminal experiment the animals were anesthetized again and both iliac arteries were exposed and outfitted with ultrasonic flow probes to measure blood flow in ml/min. These were positioned proximal to the deep femoral artery, i.e., the stem of most of the growing collateral vessels. A small PE 50 catheter was advanced through a side-branch into the abdominal aorta for the infusion of adenosine. A fluid filled catheter was introduced into the carotid artery for the measurement of systemic arterial pressure in mmHg. Both pedal arteries were prepared and catheters inserted for the measurement of the pressure gradient over the collateral network or along the intact femoral artery and its tributaries. Adenosine was infused at increasing concentrations until the central aortic pressure began to fall. This happened usually at a concentration of 600 micrograms/kg per minute. Pressure and flow signals were fed into an AD-converter and were digitally recorded on a MacLab computer.
Maximal conductances (C max ) were calculated by dividing maximal adenosinerecruited flows by the pressure gradient across the collateral network (ml/min/mmHg).
Postmortem angiography
Angiographies were performed as previously described 1 Baysian statistical analysis was performed using a paired Cyber-T test and false discovery rate (FDR)-correction of the resultant P-values was recalculated using the Benjamini-Hochberg correction for multiple testing 3, 4 . Micro array intensity differences were considered significant when absolute intensity was greater than 50 and q<0.01, Quantitative gel analysis was performed using Phosphorimager SF (Molecular Dynamics, Krefeld, Germany).
Cell Culture
Mouse vascular smooth muscle cells (MVSMC) were isolated as described earlier 6 and were cultivated in Iscove´s modified medium containing 10 % (vol/vol) heatinactivated fetal calf serum (FCS), 10 units/ml penicillin, 10 g/ml streptomycin, and 2 mM L-glutamine.
Cell proliferation assay
Cell proliferation was determined by a colorimetric immunoassay, which based on the uptake of BrdU during DNA synthesis and the quantitative binding of a monoclonal anti-BrdU-antibody (Roche Diagnostics, Mannheim, Germany). MVSMC were cultivated for 1 day in a 96-well microtiterplate. Subsequently, cells were cultivated in serum-free medium for 24 h. Thereafter, test agents were added in serum-free medium in a total volume of 100 µl/well. After incubating three days BrdUincorporation was determined.
Results
Microarray expression profiling and pathway analysis
The aim was to find candidate genes and pathways that would be responsible for the strong stimulation of collateral artery growth by increased FSS. Therefore, a genomewide expression profiling was performed directly comparing in 4 individual rabbits the collaterals from shunt versus ligated side that were harvested 7 days after the initial surgery. Expression profiling was performed using a dye-swap design, directly comparing shunt versus ligated samples from individual rabbits on duplicate arrays. A total of 10778 genes (58%) could be reliably detected in our samples using a microarray background corrected intensity cut-off of 20. Reliable differences in expression were determined by Bayesian statistical analysis, including correction for multiple testing 3 , which yield a total of 366 differentially expressed genes (Bayesian FDRcorrected q<0.01, I>50) (Online Figure 1A) . Further analysis by hierarchical clustering showed a good correlation in gene expression profiles between the 4 individual rabbits (Online Figure 1B) . Next, biological significance was determined by ranking the genes by ontology term using GenMAPP/MAPPfinder pathway analysis software. Figure 1C ), indicating that a number of diverse signaling pathways is operational during sustained remodeling in the shunted side, like RhoA, cofilin and vimentin that were up-regulated more than 5-fold.
L-NAME (but not L-NNA) inhibited cell proliferation in MVSMC
To confirm the in vivo results of the inhibitory effect of L-NAME on collateral artery growth, the effect of L-NAME and L-NNA was analyzed in vitro. Influence of L-NAME on FCS-and fibroblast-growth-factor-2 (FGF-2)-induced cell proliferation was determined by measurements of DNA synthesis in MVSMC. FCS or FGF increased DNA synthesis 18 and 1.7 fold, which both were significantly inhibited by L-NAME but not by L-NNA. L-NAME did not change DNA synthesis of unstimulated cells. The inhibitory action of L-NAME started at concentrations of 250micromolar. It is of note that the NO donor SNAP exerted also a potent anti-proliferative effect. 
